Dubbed a "challenge trial," several hundred young, healthy volunteers would be purposely exposed to the virus after receiving either a test vaccine or a placebo, the goal being to assess whether or not the test vaccine works as expected. This would allow a Wuhan coronavirus (COVID-19) vaccine to hit the market much sooner than normal.
Led by Representatives Bill Foster (D-Ill.) and Donna Shalala (D-Fla.), the latter being a former secretary of the Department of Health and Human Services (HHS), the initiative aims to bypass the traditional clinical trial process and fast-track approval for a new vaccine for the Wuhan coronavirus (COVID-19).
"Our situation in this pandemic is analogous to war, in which there is a long tradition of volunteers risking their health and lives on dangerous missions for which they understand the risks and are willing to do so in order to help save the lives of others," their letter to the FDA reads.
This is certainly music to the ears of eugenicist Bill Gates, who has repeatedly stated that Americans will not be allowed to go back to work or live anything remotely resembling a normal life until a vaccine for the Wuhan coronavirus (COVID-19) becomes commercially available.
Listen below to The Health Ranger Report as Mike Adams, the Health Ranger, warns that media outlets on both sides of the political aisle are pushing a global vaccine agenda in response to the Wuhan coronavirus (COVID-19) pandemic:
The idea of conducting a challenge trial such as this has also been endorsed by Stanley Plotkin, a vaccinologist who played a critical role in the development of the first vaccine for rubella.
In an article published in the journal Vaccine, Plotkin, along with bioethicist Arthur Caplan, attempted to make the argument that it takes too darn long to develop a vaccine the normal way, and that regulators need to speed up the process so Big Pharma can rake in the cash more quickly.
The traditional vaccine trial process, they explain, "normally takes months to years, during which [coronavirus] will infect and possibly kill millions." They further contend that "[a]cceleration of that standard process is necessary."
So what we are seeing here is the vaccine industry using key assets in the field of medicine to push the notion that the normal clinical trial process for vaccine approval is outdated and ineffective. Instead, we need to get vaccines out the door much more quickly, they insist.
The irony of a challenge trial, of course, is that it constitutes the very thing vaccine safety advocates have been pushing for years: to test new vaccine candidates against actual placebos rather than against other vaccines.
We have long been told that such tests would be "unethical" because they would deprive some participants of "life-saving vaccines." And yet, now that the Wuhan coronavirus (COVID-19) is here and the vaccine industry is chomping at the bit to gain approval for a new vaccine, it is suddenly no big deal to test experimental injections on unwitting participants using actual placebo vaccines.
"We should move the risk benefit optimization a little in favor of more rapid and riskier vaccine approval," argues Marc Lipsitch, a professor of epidemiology at Harvard University. Even if it is just "a month earlier," he says, "then there will be tens of thousands of people whose lives have been saved."
To keep up with the latest news about the Wuhan coronavirus (COVID-19), be sure to check out Pandemic.news.
Sources for this article include: